Vivos Therapeutics, Inc.

VVOS ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Apr 22, 2026 8-K
8-K Apr 15, 2026 8-K
10-K Apr 15, 2026 10-K
3 Apr 10, 2026 3
8-K Apr 3, 2026 8-K
4 Apr 2, 2026 4
SCHEDULE 13D Apr 2, 2026
NT 10-K Mar 31, 2026 NT 10-K
UPLOAD Feb 23, 2026
S-3 Feb 17, 2026 S-3
3 Feb 13, 2026 3
8-K Feb 6, 2026 8-K
8-K Jan 20, 2026 8-K
8-K Jan 16, 2026 8-K
424B3 Jan 14, 2026 424B3
EFFECT Jan 7, 2026
POS AM Jan 2, 2026 POS AM
8-K Dec 17, 2025 8-K
8-K Dec 5, 2025 8-K
8-K Nov 19, 2025 8-K
10-Q Nov 19, 2025 10-Q
NT 10-Q Nov 14, 2025 NT 10-Q
8-K Nov 4, 2025 8-K
424B5 Oct 24, 2025 424B5
8-K Oct 24, 2025 8-K
← Newer Page 2 of 12 · 287 filings Older →